Comments on: EACR-23: Shorter multimarker signatures: a new tool to facilitate cancer diagnosis https://www.elarapharma.com/eacr-23-shorter-multimarker-signatures-a-new-tool-to-facilitate-cancer-diagnosis/?utm_source=rss&utm_medium=rss&utm_campaign=eacr-23-shorter-multimarker-signatures-a-new-tool-to-facilitate-cancer-diagnosis The AI DRUG Development Company Tue, 14 Dec 2021 19:04:43 +0000 hourly 1 https://wordpress.org/?v=5.8.2